Keymed Biosciences, Inc. (HK:2162)
:2162
Comparison Results
Keymed Biosciences, Inc.
HK$62.80
HK$21.06B
-25.84
83.82%
3 Buy
0 Hold
0 Sell
Strong Buy
Ascletis Pharma, Inc.
HK$17.95
HK$19.05B
-9.33
272.41%
2 Buy
1 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$13.74
HK$35.66B
20.38
74.59%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.55B
-77.24
66.12%
2 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$24.51B
42.36
384.65%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
75.00
29.70
65.56%
HK:1672
Ascletis Pharma, Inc.
17.95
12.18
211.09%
HK:2096
Simcere Pharmaceutical Group Limited
13.74
5.70
70.90%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.78
1.61
38.61%
HK:2171
CARsgen Therapeutics Holdings Ltd.
18.24
5.42
42.28%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
60.00
47.72
388.60%